申请人:Research Development Foundation
公开号:US05674876A1
公开(公告)日:1997-10-07
The present invention provides an antiproliferative p-heteroatom-substituted phenol compound having the structure formula ##STR1## wherein m is 0 to 3, n is 0 to 4 when Het is nitrogen, wherein R is selected from the group consisting of hydrogen, alkyl, arylmethyl and acyl; R.sup.1 is alkyl; R.sup.2 is selected from the group consisting of hydrogen and alkyl; R.sup.3 is selected from the group consisting of alkyl and acyl when Het is nitrogen, R.sup.4 is selected from the group consisting of hydrogen and alkyl; R.sup.5 is selected from the group consisting of hydrogen and alkyl; and R.sup.6 and R.sup.7 are selected from the group consisting of hydrogen, alkyl and R.sup.6 and R.sup.7 together may represent oxygen. Also provided are various methods for the treatment of a pathological cell proliferative disease comprising administering to an animal) a pharmacologically and therapeutically effective dose of a pharmaceutical composition comprising a p-heteroatom-substituted phenols or an analog thereof.
本发明提供了一种具有结构式的抗增殖p-杂原子取代酚化合物##STR1##其中m为0至3,n为0至4,当Het为氮时,其中R选自氢、烷基、芳基甲基和酰基组成的群;R.sup.1为烷基;R.sup.2选自氢和烷基;R.sup.3选自烷基和酰基,当Het为氮时,R.sup.4选自氢和烷基;R.sup.5选自氢和烷基;以及R.sup.6和R.sup.7选自氢、烷基和R.sup.6和R.sup.7可以一起代表氧。还提供了治疗病理细胞增生性疾病的各种方法,包括向动物)施用含有p-杂原子取代酚或其类似物的药物组成的药物学和治疗学有效剂量。